Literature DB >> 3901454

Medullary carcinoma of the thyroid gland: an immunocytochemical study.

R Holm, M Sobrinho-Simões, J M Nesland, V E Gould, J V Johannessen.   

Abstract

Twenty-seven cases of medullary carcinoma of the thyroid gland (MCT) were studied by light microscopy, immunocytochemistry, and electron microscopy. Immunoreactivity for neuron-specific enolase (NSE) and calcitonin was present in all tumors. The numbers of peptides and serotonin demonstrated in each case varied from one to eight. Bombesin was present in 18 of the 27 cases, serotonin in 15, leu-enkephalin in 8, somatostatin in 8, gastrin in 3, substance P in 1, vasoactive intestinal peptide (VIP) in 1, and ACTH in 1. Insulin and glucagon were not encountered in any of the tumors. Immunoreactivity for thyroglobulin was seen in five primary tumors as well as in one lymph node metastasis. The finding of concurrent production of calcitonin and thyroglobulin within the same tumor is enough to question the dogma of the separate origin of follicular cells and C-cells. We were unable to attach any clinical importance to the production of multiple peptides and/or amines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3901454     DOI: 10.3109/01913128509141506

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  13 in total

Review 1.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

Review 2.  Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

Authors:  Ying-Hsia Chu; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

3.  Hyalinizing trabecular adenoma: A misnomer for a peculiar tumor of the thyroid gland.

Authors:  Clara Sambade; Kaarle Franssila; José Cameselle-Teijeiro; Jahn Nesland; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  1991-06       Impact factor: 3.943

4.  Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.

Authors:  S Schröder; W Schwarz; W Rehpenning; H Dralle; V Bay; W Böcker
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma.

Authors:  N Neuhold; F Längle; M Gnant; U Hollenstein; B Niederle
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Blood group antigen expression in malignant tumors of the thyroid: a parallel between medullary and nonmedullary carcinomas.

Authors:  A Larena; M Vierbuchen; R Fischer
Journal:  Langenbecks Arch Chir       Date:  1995

7.  The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases.

Authors:  Mauro Papotti; Daniela Sambataro; Carla Pecchioni; Gianni Bussolati
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

8.  Ultrastructural and electron immunohistochemical features of medullary thyroid carcinoma.

Authors:  R Holm; G W Farrants; J M Nesland; M Sobrinho-Simões; O G Jørgensen; J V Johannessen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

9.  Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors.

Authors:  R V Lloyd; J C Sisson; B Shapiro; A A Verhofstad
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

10.  Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.

Authors:  Valdemar Máximo; Ana Preto; Ana Crespo; Ana Sofia Rocha; José Carlos Machado; Paula Soares; Manuel Sobrinho-Simões
Journal:  BMC Cancer       Date:  2004-03-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.